Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2310016C 16Rik | |
NM_027127 |
RIKEN cDNA 2310016C16 gene (2310016C16Rik), mRNA [NM_027127] |
KLA | .94 |
1.03 |
1.06 |
1.07 |
.99 |
1.05 |
.96 |
| ATP | .97 |
1.01 |
1.01 |
1.04 |
1.01 |
1.07 |
1.05 |
| KLA/ATP | 1.04 |
1.08 |
1.09 |
1.01 |
1.03 |
1.02 |
.98 |
|
A030007L 17Rik | |
AK141474 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530031D20 product:hypothetical protein, full insert sequence [AK141474] |
KLA | 1.26 |
1.19 |
1.43 |
1.39 |
1.24 |
1.31 |
1.56 |
| ATP | .97 |
.99 |
1.12 |
1.08 |
1.10 |
1.16 |
.89 |
| KLA/ATP | 1.23 |
1.32 |
1.43 |
1.48 |
1.28 |
1.19 |
1.15 |
|
A030007L 17Rik | |
NM_026637 |
RIKEN cDNA A030007L17 gene (A030007L17Rik), mRNA [NM_026637] |
KLA | 6.22 |
6.74 |
6.79 |
7.51 |
6.56 |
6.78 |
7.05 |
| ATP | .93 |
.89 |
1.27 |
1.51 |
1.86 |
3.50 |
1.36 |
| KLA/ATP | 6.28 |
6.62 |
9.59 |
9.74 |
8.71 |
5.46 |
5.01 |
|
Anpep | |
NM_008486 |
alanyl (membrane) aminopeptidase (Anpep), mRNA [NM_008486] |
KLA | .93 |
.81 |
.87 |
.91 |
1.05 |
1.06 |
.71 |
| ATP | .99 |
.98 |
1.00 |
1.08 |
1.04 |
.93 |
1.45 |
| KLA/ATP | .85 |
.89 |
.82 |
.97 |
.97 |
.93 |
.90 |
|
G6pd2 | |
NM_019468 |
glucose-6-phosphate dehydrogenase 2 (G6pd2), mRNA [NM_019468] |
KLA | 1.07 |
1.13 |
1.31 |
.96 |
1.22 |
1.19 |
1.70 |
| ATP | 1.23 |
1.51 |
.85 |
1.48 |
.93 |
.89 |
1.34 |
| KLA/ATP | 1.56 |
1.52 |
.71 |
1.40 |
.72 |
1.04 |
2.61 |
|
G6pdx | |
NM_008062 |
glucose-6-phosphate dehydrogenase X-linked (G6pdx), mRNA [NM_008062] |
KLA | .77 |
.81 |
.85 |
.74 |
.84 |
.90 |
1.44 |
| ATP | 1.11 |
1.12 |
.85 |
.85 |
.76 |
.86 |
1.07 |
| KLA/ATP | .96 |
.88 |
.63 |
.72 |
.58 |
.77 |
1.91 |
|
Gclc | |
NM_010295 |
glutamate-cysteine ligase, catalytic subunit (Gclc), mRNA [NM_010295] |
KLA | .42 |
.38 |
.24 |
.19 |
.22 |
.26 |
.59 |
| ATP | 1.07 |
1.03 |
1.24 |
2.13 |
4.71 |
25.45 |
1.33 |
| KLA/ATP | .35 |
.36 |
.44 |
1.21 |
2.16 |
4.41 |
1.54 |
|
Gclm | |
NM_008129 |
glutamate-cysteine ligase , modifier subunit (Gclm), mRNA [NM_008129] |
KLA | .87 |
.91 |
.79 |
.58 |
.46 |
.46 |
1.30 |
| ATP | 1.26 |
1.41 |
.93 |
1.28 |
2.39 |
5.57 |
2.40 |
| KLA/ATP | .98 |
1.10 |
.59 |
.93 |
.97 |
2.74 |
2.75 |
|
Ggt1 | |
NM_008116 |
gamma-glutamyltransferase 1 (Ggt1), mRNA [NM_008116] |
KLA | 1.03 |
1.00 |
1.00 |
1.05 |
1.00 |
1.02 |
1.02 |
| ATP | 1.00 |
1.00 |
.96 |
1.00 |
1.03 |
1.02 |
.99 |
| KLA/ATP | .98 |
.99 |
1.04 |
1.00 |
.99 |
.98 |
.98 |
|
Ggt5 | |
NM_011820 |
gamma-glutamyltransferase 5 (Ggt5), mRNA [NM_011820] |
KLA | .89 |
.91 |
.92 |
.89 |
.86 |
.79 |
.58 |
| ATP | 1.00 |
1.03 |
.93 |
.97 |
.84 |
.80 |
.59 |
| KLA/ATP | 1.00 |
.92 |
.93 |
.98 |
.83 |
.79 |
.68 |
|
Ggt6 | |
NM_027819 |
gamma-glutamyltransferase 6 (Ggt6), mRNA [NM_027819] |
KLA | 1.03 |
.90 |
.98 |
1.07 |
1.00 |
1.02 |
.98 |
| ATP | 1.02 |
1.07 |
.90 |
1.02 |
1.03 |
1.03 |
.94 |
| KLA/ATP | .99 |
1.04 |
.98 |
.97 |
1.02 |
1.01 |
.96 |
|
Ggt7 | |
NM_144786 |
gamma-glutamyltransferase 7 (Ggt7), mRNA [NM_144786] |
KLA | .96 |
1.03 |
.97 |
1.01 |
1.00 |
.98 |
.89 |
| ATP | 1.03 |
1.02 |
1.01 |
.92 |
.94 |
.97 |
1.00 |
| KLA/ATP | .98 |
.95 |
1.05 |
.89 |
.92 |
.94 |
.94 |
|
Gpx1 | |
NM_008160 |
glutathione peroxidase 1 (Gpx1), mRNA [NM_008160] |
KLA | .63 |
.68 |
.67 |
.51 |
.52 |
.48 |
.64 |
| ATP | 1.02 |
1.01 |
.85 |
.91 |
.66 |
.41 |
.97 |
| KLA/ATP | .76 |
.73 |
.47 |
.61 |
.45 |
.39 |
.70 |
|
Gpx2 | |
NM_030677 |
glutathione peroxidase 2 (Gpx2), mRNA [NM_030677] |
KLA | .69 |
.71 |
.59 |
.69 |
.72 |
.69 |
.69 |
| ATP | 1.08 |
1.10 |
.74 |
.79 |
.77 |
.66 |
.64 |
| KLA/ATP | .70 |
.65 |
.69 |
.74 |
.78 |
.76 |
.53 |
|
Gpx3 | |
NM_008161 |
glutathione peroxidase 3 (Gpx3), transcript variant 2, mRNA [NM_008161] |
KLA | 1.14 |
1.14 |
1.20 |
1.09 |
1.07 |
.85 |
.50 |
| ATP | 1.15 |
1.15 |
1.00 |
1.84 |
1.10 |
.96 |
.62 |
| KLA/ATP | 1.14 |
1.17 |
.93 |
1.48 |
.90 |
.99 |
.64 |
|
Gpx4 | |
NM_001037741 |
glutathione peroxidase 4 (Gpx4), transcript variant 1, mRNA [NM_001037741] |
KLA | .80 |
.72 |
.64 |
.64 |
.66 |
.58 |
.94 |
| ATP | 1.08 |
1.14 |
.98 |
1.11 |
1.06 |
1.00 |
1.28 |
| KLA/ATP | .79 |
.80 |
.76 |
.86 |
.82 |
.97 |
1.24 |
|
Gpx5 | |
X53780 |
gb|Mouse mRNA for 24kDa major androgen regulated protein, arMEP24. [X53780] |
KLA | .95 |
1.02 |
.99 |
.99 |
.97 |
1.06 |
.98 |
| ATP | 1.04 |
.94 |
.96 |
1.05 |
1.02 |
1.01 |
.98 |
| KLA/ATP | .98 |
1.00 |
.98 |
.93 |
1.00 |
1.07 |
.99 |
|
Gpx6 | |
NM_145451 |
glutathione peroxidase 6 (Gpx6), mRNA [NM_145451] |
KLA | 1.00 |
1.05 |
1.02 |
.99 |
1.04 |
1.03 |
.94 |
| ATP | .98 |
1.03 |
1.04 |
.91 |
.92 |
1.03 |
1.05 |
| KLA/ATP | .99 |
1.01 |
1.04 |
.99 |
.96 |
.89 |
1.02 |
|
Gpx7 | |
NM_024198 |
glutathione peroxidase 7 (Gpx7), mRNA [NM_024198] |
KLA | .91 |
1.00 |
.95 |
.96 |
.87 |
.90 |
.83 |
| ATP | 1.00 |
1.07 |
1.06 |
1.07 |
.94 |
.93 |
.88 |
| KLA/ATP | .96 |
1.01 |
.95 |
.98 |
.82 |
.90 |
.86 |
|
Gsr | |
NM_010344 |
glutathione reductase (Gsr), mRNA [NM_010344] |
KLA | 1.18 |
1.27 |
1.29 |
1.51 |
1.98 |
1.54 |
2.62 |
| ATP | 1.04 |
1.20 |
.99 |
1.27 |
1.39 |
4.78 |
1.69 |
| KLA/ATP | 1.22 |
1.40 |
1.01 |
1.50 |
1.19 |
2.85 |
4.25 |
|
Gss | |
NM_008180 |
glutathione synthetase (Gss), mRNA [NM_008180] |
KLA | 1.21 |
1.26 |
1.25 |
1.17 |
1.00 |
.75 |
1.11 |
| ATP | 1.06 |
1.12 |
1.04 |
1.21 |
3.15 |
7.87 |
2.60 |
| KLA/ATP | 1.24 |
1.35 |
1.22 |
1.38 |
2.28 |
4.32 |
2.63 |
|
Gsta1 | |
NM_008181 |
glutathione S-transferase, alpha 1 (Ya) (Gsta1), mRNA [NM_008181] |
KLA | .94 |
1.06 |
1.07 |
.99 |
.99 |
1.13 |
1.08 |
| ATP | 1.01 |
1.00 |
1.07 |
1.04 |
1.13 |
1.82 |
3.26 |
| KLA/ATP | 1.04 |
.96 |
.98 |
1.12 |
1.15 |
1.07 |
1.39 |
|
Gsta2 | |
NM_008182 |
glutathione S-transferase, alpha 2 (Yc2) (Gsta2), mRNA [NM_008182] |
KLA | 1.01 |
.97 |
.99 |
.97 |
.98 |
1.02 |
.93 |
| ATP | 1.04 |
1.03 |
.98 |
.93 |
1.05 |
1.54 |
2.11 |
| KLA/ATP | 1.00 |
.97 |
1.05 |
1.01 |
.97 |
1.03 |
1.14 |
|
Gsta3 | |
NM_001077353 |
glutathione S-transferase, alpha 3 (Gsta3), transcript variant 1, mRNA [NM_001077353] |
KLA | .93 |
.95 |
.88 |
.86 |
.60 |
.52 |
.91 |
| ATP | 1.00 |
.95 |
1.30 |
1.00 |
.97 |
2.01 |
4.26 |
| KLA/ATP | .93 |
1.03 |
1.22 |
.97 |
.77 |
.75 |
3.30 |
|
Gsta4 | |
NM_010357 |
glutathione S-transferase, alpha 4 (Gsta4), mRNA [NM_010357] |
KLA | 1.03 |
1.00 |
1.00 |
.99 |
.99 |
.98 |
.96 |
| ATP | .99 |
1.03 |
.98 |
.99 |
.99 |
1.09 |
1.25 |
| KLA/ATP | 1.02 |
1.01 |
1.01 |
.99 |
.96 |
1.00 |
1.04 |
|
Gstk1 | |
AK002661 |
adult male kidney cDNA, RIKEN full-length enriched library, clone:0610025I19 product:GLUTATHIONE S-TRANSFERASE, MITOCHONDRIAL (EC 2.5.1.18) (GST 13-13) (GLUTATHIONE S-TRANSFERASE SUBUNIT 13) (GST CLASS-KAPPA) homolog [Rattus norvegicus], |
KLA | 1.05 |
1.02 |
1.06 |
1.05 |
.91 |
.81 |
.60 |
| ATP | .93 |
.85 |
1.40 |
1.29 |
1.23 |
1.00 |
.72 |
| KLA/ATP | .98 |
1.09 |
1.61 |
1.33 |
1.36 |
.86 |
.62 |
|
Gstm1 | |
NM_010358 |
glutathione S-transferase, mu 1 (Gstm1), mRNA [NM_010358] |
KLA | .94 |
.95 |
1.04 |
.94 |
.85 |
.74 |
.76 |
| ATP | 1.12 |
1.15 |
1.17 |
1.92 |
1.78 |
2.30 |
2.03 |
| KLA/ATP | 1.12 |
1.15 |
1.06 |
1.74 |
1.66 |
2.20 |
3.26 |
|
Gstm2 | |
NM_008183 |
glutathione S-transferase, mu 2 (Gstm2), mRNA [NM_008183] |
KLA | 1.23 |
1.15 |
1.23 |
1.24 |
1.20 |
1.07 |
.96 |
| ATP | 1.11 |
1.06 |
1.37 |
1.96 |
2.12 |
2.41 |
5.20 |
| KLA/ATP | 1.18 |
1.33 |
1.57 |
1.98 |
1.96 |
1.90 |
3.42 |
|
Gstm3 | |
NM_010359 |
glutathione S-transferase, mu 3 (Gstm3), mRNA [NM_010359] |
KLA | .88 |
.88 |
.84 |
.79 |
.78 |
.69 |
.70 |
| ATP | .99 |
1.04 |
1.13 |
1.58 |
1.64 |
1.88 |
1.81 |
| KLA/ATP | .93 |
.94 |
.99 |
1.47 |
1.54 |
1.92 |
2.72 |
|
Gstm4 | |
NM_026764 |
glutathione S-transferase, mu 4 (Gstm4), mRNA [NM_026764] |
KLA | .91 |
.98 |
.95 |
.98 |
1.04 |
.94 |
1.45 |
| ATP | 1.08 |
1.15 |
.86 |
1.13 |
.83 |
.63 |
1.19 |
| KLA/ATP | 1.03 |
1.07 |
.90 |
.92 |
.64 |
.76 |
1.82 |
|
Gstm5 | |
NM_010360 |
glutathione S-transferase, mu 5 (Gstm5), mRNA [NM_010360] |
KLA | 1.00 |
1.11 |
.97 |
.99 |
.88 |
.64 |
.53 |
| ATP | 1.02 |
1.13 |
1.18 |
1.47 |
1.17 |
.86 |
.76 |
| KLA/ATP | 1.16 |
1.13 |
1.09 |
1.38 |
1.01 |
.73 |
.62 |
|
Gstm6 | |
NM_008184 |
glutathione S-transferase, mu 6 (Gstm6), mRNA [NM_008184] |
KLA | 1.00 |
.99 |
.99 |
1.02 |
1.05 |
.98 |
.99 |
| ATP | .96 |
.97 |
.98 |
.99 |
1.10 |
.95 |
.99 |
| KLA/ATP | .98 |
.92 |
1.02 |
1.01 |
1.05 |
.97 |
1.00 |
|
Gstm7 | |
AK002213 |
adult male kidney cDNA, RIKEN full-length enriched library, clone:0610005A07 product:GLUTATHIONE S-TRANSFERASE, MU TYPE 3 (YB3) homolog [Mus musculus], full insert sequence. [AK002213] |
KLA | .99 |
.93 |
.95 |
.98 |
1.04 |
.98 |
.92 |
| ATP | 1.03 |
1.01 |
.98 |
.97 |
.98 |
.98 |
.98 |
| KLA/ATP | .92 |
.92 |
.98 |
.91 |
1.00 |
.92 |
.99 |
|
Gstm7 | |
NM_026672 |
glutathione S-transferase, mu 7 (Gstm7), mRNA [NM_026672] |
KLA | .97 |
1.03 |
.96 |
1.02 |
.91 |
.96 |
.95 |
| ATP | 1.02 |
.99 |
1.00 |
1.00 |
1.00 |
.88 |
.90 |
| KLA/ATP | 1.00 |
1.03 |
.95 |
.96 |
1.01 |
.95 |
.89 |
|
Gsto1 | |
NM_010362 |
glutathione S-transferase omega 1 (Gsto1), mRNA [NM_010362] |
KLA | .84 |
.81 |
.84 |
.76 |
.62 |
.54 |
.61 |
| ATP | 1.09 |
1.04 |
1.23 |
1.78 |
1.95 |
1.75 |
.96 |
| KLA/ATP | .88 |
.87 |
1.05 |
1.30 |
1.31 |
1.18 |
.77 |
|
Gsto2 | |
NM_026619 |
glutathione S-transferase omega 2 (Gsto2), mRNA [NM_026619] |
KLA | 1.03 |
1.07 |
1.03 |
1.00 |
.98 |
1.12 |
1.10 |
| ATP | .94 |
.90 |
1.01 |
2.25 |
1.86 |
1.00 |
1.03 |
| KLA/ATP | .98 |
.96 |
1.02 |
1.87 |
2.11 |
1.15 |
1.21 |
|
Gstp1 | |
NM_013541 |
glutathione S-transferase, pi 1 (Gstp1), mRNA [NM_013541] |
KLA | .99 |
.99 |
.98 |
.92 |
.92 |
.79 |
.85 |
| ATP | 1.06 |
1.10 |
1.06 |
1.27 |
1.13 |
1.62 |
2.31 |
| KLA/ATP | .98 |
1.02 |
1.03 |
1.22 |
1.02 |
1.25 |
2.47 |
|
Gstt1 | |
NM_008185 |
glutathione S-transferase, theta 1 (Gstt1), mRNA [NM_008185] |
KLA | 1.23 |
1.46 |
1.64 |
1.80 |
2.33 |
3.37 |
4.15 |
| ATP | 1.02 |
1.03 |
1.10 |
1.18 |
1.01 |
1.05 |
.99 |
| KLA/ATP | 1.43 |
1.61 |
1.40 |
1.58 |
1.37 |
1.43 |
2.11 |
|
Gstt2 | |
NM_010361 |
glutathione S-transferase, theta 2 (Gstt2), mRNA [NM_010361] |
KLA | 1.05 |
1.08 |
1.02 |
1.08 |
1.33 |
1.48 |
1.33 |
| ATP | .96 |
.98 |
.96 |
1.15 |
1.07 |
.76 |
1.12 |
| KLA/ATP | 1.02 |
1.07 |
1.20 |
1.41 |
1.41 |
1.23 |
2.59 |
|
Gstt3 | |
NM_133994 |
glutathione S-transferase, theta 3 (Gstt3), mRNA [NM_133994] |
KLA | .78 |
.79 |
.76 |
.74 |
.68 |
.65 |
.61 |
| ATP | .96 |
.87 |
.93 |
.82 |
.63 |
.42 |
.74 |
| KLA/ATP | .76 |
.75 |
.89 |
.76 |
.68 |
.74 |
2.44 |
|
Idh1 | |
NM_010497 |
isocitrate dehydrogenase 1 (NADP+), soluble (Idh1), transcript variant 2, mRNA [NM_010497] |
KLA | .71 |
.74 |
.69 |
.70 |
.54 |
.45 |
.63 |
| ATP | 1.22 |
1.28 |
1.00 |
1.28 |
1.06 |
.62 |
.81 |
| KLA/ATP | .76 |
.81 |
.68 |
.88 |
.55 |
.47 |
.40 |
|
Idh2 | |
NM_173011 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial (Idh2), nuclear gene encoding mitochondrial protein, mRNA [NM_173011] |
KLA | .83 |
.83 |
.88 |
.94 |
.66 |
.31 |
.38 |
| ATP | 1.04 |
1.09 |
1.14 |
1.48 |
1.26 |
.39 |
.49 |
| KLA/ATP | .90 |
.92 |
1.04 |
1.10 |
.82 |
.41 |
.20 |
|
Lap3 | |
NM_024434 |
leucine aminopeptidase 3 (Lap3), mRNA [NM_024434] |
KLA | 2.95 |
3.13 |
3.13 |
3.67 |
3.18 |
2.01 |
1.07 |
| ATP | 1.02 |
1.02 |
1.23 |
1.18 |
1.30 |
1.63 |
.91 |
| KLA/ATP | 2.72 |
3.04 |
4.11 |
3.89 |
3.99 |
3.42 |
.86 |
|
Mgst1 | |
NM_019946 |
microsomal glutathione S-transferase 1 (Mgst1), mRNA [NM_019946] |
KLA | 1.00 |
1.03 |
1.02 |
1.00 |
1.03 |
1.03 |
1.68 |
| ATP | 1.01 |
1.02 |
1.12 |
1.22 |
1.38 |
2.86 |
2.13 |
| KLA/ATP | 1.01 |
1.06 |
1.06 |
1.28 |
1.38 |
2.77 |
3.05 |
|
Mgst2 | |
NM_174995 |
microsomal glutathione S-transferase 2 (Mgst2), mRNA [NM_174995] |
KLA | 2.87 |
2.54 |
2.80 |
3.26 |
2.70 |
2.43 |
1.43 |
| ATP | 1.04 |
1.05 |
1.48 |
1.33 |
1.13 |
1.39 |
6.05 |
| KLA/ATP | 2.10 |
2.54 |
4.49 |
3.33 |
2.57 |
1.87 |
3.13 |
|
Mgst3 | |
AK008211 |
adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010012L10 product:RIKEN cDNA 2010012L10 gene, full insert sequence. [AK008211] |
KLA | 1.04 |
.98 |
.89 |
.88 |
.69 |
.44 |
.15 |
| ATP | 1.05 |
1.16 |
1.34 |
1.66 |
1.17 |
.70 |
.25 |
| KLA/ATP | .94 |
1.02 |
1.07 |
1.41 |
1.02 |
.72 |
.15 |
|
Mgst3 | |
NM_025569 |
microsomal glutathione S-transferase 3 (Mgst3), mRNA [NM_025569] |
KLA | 1.04 |
1.03 |
.87 |
.83 |
.69 |
.47 |
.17 |
| ATP | 1.00 |
1.13 |
1.18 |
1.47 |
1.16 |
.69 |
.26 |
| KLA/ATP | 1.02 |
.98 |
.92 |
1.29 |
.93 |
.74 |
.17 |
|
Mm.1332 | |
171543845 |
Unknown |
KLA | .95 |
.97 |
.87 |
.99 |
.98 |
.98 |
1.04 |
| ATP | 1.00 |
.93 |
1.00 |
1.08 |
.95 |
1.02 |
.92 |
| KLA/ATP | 1.03 |
1.12 |
.94 |
.98 |
1.01 |
.91 |
1.10 |
|
Mm.39459 3 | |
116325998 |
Unknown |
KLA | .96 |
1.01 |
.98 |
.95 |
.98 |
.93 |
1.03 |
| ATP | 1.00 |
.98 |
.97 |
1.12 |
1.01 |
1.00 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.00 |
.98 |
1.04 |
1.01 |
1.05 |
|
Mm.42277 8 | |
118130920 |
Unknown |
KLA | 1.00 |
1.01 |
1.08 |
1.04 |
.99 |
.98 |
1.01 |
| ATP | 1.07 |
1.11 |
1.03 |
.98 |
1.08 |
2.66 |
3.31 |
| KLA/ATP | .95 |
1.05 |
1.04 |
.96 |
1.00 |
1.14 |
1.44 |
|
Odc1 | |
NM_013614 |
ornithine decarboxylase, structural 1 (Odc1), mRNA [NM_013614] |
KLA | 2.10 |
1.85 |
1.51 |
1.36 |
1.07 |
.99 |
.71 |
| ATP | 1.15 |
1.53 |
4.90 |
11.04 |
12.87 |
14.66 |
2.00 |
| KLA/ATP | 2.01 |
1.77 |
3.11 |
5.19 |
5.52 |
7.17 |
4.50 |
|
Oplah | |
NM_153122 |
5-oxoprolinase (ATP-hydrolysing) (Oplah), mRNA [NM_153122] |
KLA | .96 |
.99 |
.99 |
.95 |
.95 |
1.05 |
.90 |
| ATP | 1.02 |
1.02 |
.95 |
.96 |
.93 |
1.28 |
.83 |
| KLA/ATP | 1.01 |
.93 |
.91 |
.93 |
1.09 |
1.48 |
1.16 |
|
Pgd | |
NM_001081274 |
phosphogluconate dehydrogenase (Pgd), mRNA [NM_001081274] |
KLA | .91 |
.94 |
.94 |
.76 |
.80 |
.67 |
.93 |
| ATP | 1.11 |
1.22 |
.84 |
.96 |
1.20 |
1.82 |
1.59 |
| KLA/ATP | 1.01 |
1.10 |
.79 |
.90 |
.83 |
1.30 |
1.75 |
|
Rrm1 | |
AK049601 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530001L22 product:ribonucleotide reductase M1, full insert sequence. [AK049601] |
KLA | .99 |
.96 |
1.17 |
1.00 |
1.00 |
.88 |
.97 |
| ATP | 1.07 |
.98 |
.94 |
.96 |
.92 |
.86 |
.99 |
| KLA/ATP | 1.00 |
1.03 |
1.00 |
.96 |
1.02 |
1.00 |
.95 |
|
Rrm1 | |
NM_009103 |
ribonucleotide reductase M1 (Rrm1), mRNA [NM_009103] |
KLA | .47 |
.46 |
.38 |
.28 |
.18 |
.21 |
.17 |
| ATP | .97 |
1.01 |
1.06 |
.97 |
.65 |
.27 |
.18 |
| KLA/ATP | .46 |
.42 |
.39 |
.36 |
.23 |
.16 |
.11 |
|
Rrm2 | |
NM_009104 |
ribonucleotide reductase M2 (Rrm2), mRNA [NM_009104] |
KLA | .32 |
.27 |
.23 |
.17 |
.13 |
.13 |
.12 |
| ATP | .98 |
1.00 |
1.17 |
1.28 |
.66 |
.20 |
.08 |
| KLA/ATP | .28 |
.25 |
.30 |
.30 |
.23 |
.13 |
.08 |
|
Rrm2b | |
NM_199476 |
ribonucleotide reductase M2 B (TP53 inducible) (Rrm2b), mRNA [NM_199476] |
KLA | .93 |
.90 |
.89 |
.95 |
.97 |
1.00 |
1.13 |
| ATP | .96 |
.95 |
.95 |
.87 |
.75 |
.80 |
.90 |
| KLA/ATP | .84 |
.85 |
.89 |
.84 |
.78 |
.78 |
.88 |
|
Sms | |
NM_009214 |
spermine synthase (Sms), mRNA [NM_009214] |
KLA | 1.18 |
1.13 |
1.09 |
1.03 |
.91 |
.68 |
.62 |
| ATP | .99 |
1.03 |
.86 |
.77 |
.69 |
.49 |
.56 |
| KLA/ATP | 1.08 |
1.13 |
.92 |
.80 |
.62 |
.42 |
.32 |
|
Srm | |
NM_009272 |
spermidine synthase (Srm), mRNA [NM_009272] |
KLA | .61 |
.68 |
.55 |
.41 |
.31 |
.32 |
.57 |
| ATP | .95 |
1.06 |
.92 |
1.19 |
.94 |
.50 |
.61 |
| KLA/ATP | .70 |
.65 |
.55 |
.59 |
.44 |
.26 |
.17 |
|
Txndc12 | |
NM_025334 |
thioredoxin domain containing 12 (endoplasmic reticulum) (Txndc12), mRNA [NM_025334] |
KLA | .83 |
.84 |
.83 |
.73 |
.92 |
1.20 |
1.29 |
| ATP | .99 |
1.06 |
1.05 |
1.19 |
.98 |
.78 |
1.24 |
| KLA/ATP | .84 |
.84 |
.77 |
.92 |
.82 |
1.12 |
1.70 |
|